ReviewCureus2024

Efficacy of Different Doses and Forms of the GLP-1 Receptor Agonist Semaglutide in Weight Reduction Among Non-diabetic Obese or Overweight Populations.

Nazeefa Fatima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.